HTA18 Challenges of Identifying Health Utility Data for Patients With Penta-Refractory Multiple Myeloma to Inform HTA Reimbursement Discussion for Newer Treatment Options
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.1703
https://www.valueinhealthjournal.com/article/S1098-3015(23)04833-7/fulltext
Section Title :
Section Order :
11148
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04833-7&doi=10.1016/j.jval.2023.09.1703